I agree. The run up to ten was not sustainable. When I got in at .75 I was the idiot. I didn’t do enough due diligence and had written the entire investment off and kicked myself around the block. It wasn’t until covid emerged that I thought CYDY had any real chance and back in May I was making the same arguments you are now. What’s changed? My perception of Nader as well as BP and the FDA. This is NOT a level playing field and only FDA (MHRA) desperation for efficacy will change that. With regard to HIV...75 to 100% on your investment loses it’s luster if like me you got in 2015/15 at .75 or 2020 @10...so we are back to drum roll......COVID SEVERE.